Morgan Stanley Price Target Dropped, Analyst Sees Upside for UnitedHealth
Even as the U.S. financial stock market held support, but did not propel majorly higher on Friday, analysts provided investors with an affirmation of their ratings with adjusted price targets. Here are the companies to review:
Xyratex (NASDAQ:XRTX): Down on second quarter guidance, Western Digital (NYSE:WDC) reboots from 14 percent drop this week. Brean Murray reiterates a Buy, claiming Western Digital’s remarks about the Thai flooding impacts bode well for sales of Xyratex’s hard drive manufacturing gear.
RBC Capital Mkts reiterated Sector Perform and raised target from $11 to $16.
UnitedHealth (NYSE:UNH): Stifel Nicolaus sees United as “the only MCO truly well positioned for the changing healthcare landscape… Its nationally-focused benefits business augmented by an established and evolving services business is without peer.” Building an impression that UNH is “much more than a health insurance company” could push shares.
Stifel Nicolaus reiterated Buy and raised target from $55 to $65.
Hasbro (NYSE:HAS): Hasbro’s investor day second quarter comments have pushed the stock down the last hour.
Stifel Nicolaus reiterated Buy and lowered target from $43 to $41.
Acuity Brands (NYSE:AYI): Light Emitting Diode (LED) lighting adoption is growing and Camaccord expects lighting fixtures provider, Acuity Brands, to be a major benefactor. Adoption of LED light is being fueled by crashing LED prices. The firm feels Acuity could earn $3.50- $4 a share in 2013-2014, easily beating this year’s expected $2.42.
Kaufman Bros reiterated Hold and raised target from $39 to $51.
Clean Harbors (NYSE:CLH): Clean Harbors higher after J.P. Morgan up share valuation to overweight. The firm says hazardous waste disposal is a “recession-resistant” business, so the any economic weakening shouldn’t hurt near-term outlook.
Wunderlich reiterated Buy and raised target from $65 to $70.
Endeavour Intl (AMEX:END): Rodman & Renshaw ups Endeavour to Market Outperform with a $12.50 target. The firm notes the company has lagged peers, but issues of liquidity concerns and operational delays have been largely resolved, and the stock should move higher in 2012.
C.K. Cooper reiterated Buy and lowered target from $14 to $12.
Morgan Stanley (NYSE:MS): Ticonderoga cuts fourth quarter and fiscal year 2012 earnings-per-share estimates for Goldman Sachs (NYSE:GS) and Morgan Stanley (NYSE:MS). The firm sees a better future saying potential catalysts include signs of the U.S. economy improving, Fed stress tests improving capital availability for repurchases, and widening bid-ask spreads shoveled by “major retrenchment” of European competitors.
Ticonderoga reiterated Buy and lowered target from $22 to $19.
Jazz Pharma (NASDAQ:JAZZ): Jazz Pharmaceuticals up again after revising 2012 revenues upward yesterday.
Mizuho reiterated Buy and raised target from $52 to $62.
To contact the reporter on this story: Jim Wilkerson at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com